
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
April 10, 2025
Host Jonathan Miller interviews CEO: Ram Mukunda, who shows us how the company is pushing the boundaries of scientific discovery, creating life-changing medications, and improving the quality of life for individuals around the globe.